性激素在精神分裂症治疗中的研究进展  

Research Progress of Sex Hormones in the Treatment of Schizophrenia

作　　者：李哲[1] 武文煜[1] 贾荣 潘虹英 Li Zhe;Wu Wenyu;Jia Rong;Pan Hongying(Yunnan Mental Hospital,Kunming 650224,Yunnan Province,China)

机构地区：[1]云南省精神病医院,云南昆明650224

出　　处：《中国社区医师》2024年第27期7-9,共3页Chinese Community Doctors

摘　　要：精神分裂症是一种慢性精神疾病,其病因尚不明确、致残率较高,不同性别精神分裂症患者的临床特征、性激素水平存在差异,主要有雌激素、孕激素和雄激素。目前,已有应用雌激素治疗精神分裂症的相关研究。该文对近年来性激素治疗精神分裂症的相关研究进行综述,以期为临床诊治精神分裂症提供参考。Schizophrenia is a chronic mental disease,its etiology is not clear,the disability rate is high,different gender schizophrenia patients clinical characteristics,sex hormone levels are different,mainly estrogen,progesterone and androgen.At present,there have been studies on the use of estrogen in the treatment of schizophrenia.This article reviewed the recent studies on sex hormone therapy for schizophrenia,in order to provide reference for clinical diagnosis and treatment of schizophrenia.

关 键 词：性激素 精神分裂症 研究进展 

分 类 号：R749.3[医药卫生—神经病学与精神病学]